Glycomics Market size was expected to be worth USD 924.5 million in 2022 and is projected to grow at a 15.3% CAGR from 2023 to 2029. The study of saccharides, which are extensively found in nature and are also thought of as glycans, and their structure, biology, and function is known as glycomics or glycobiology. Glycans are found in all living organisms. Glycobiology is a rapidly progressing biological area of interest for various fields like biotechnology, biomedicine, and basic research. Most proteins are revised after the translation process in eukaryotic cells. The attachment of glycans is one of the most usual modifications for cell viability. The Enzymes segment is anticipated to grow at a significant CAGR over the forecast years due to the consumable nature of enzymes and their wide applications in a variety of R&D and drug discovery procedures. The glycose of a tissue, cell, or organism can be quantified or defined using a variety of research techniques in Glycosmis. The final glycan structure changes because of changes in location or the activity of the enzymes involved in glycan production. As a result, in addition to genetic markers for people, glycan analysis may be used to evaluate alterations brought on by the environment. This research can be used to find new medicines and diagnose diseases. One of the main drivers of segment expansion is this. Increase in demand for research activities on glycomics, rising R&D investments in pharmaceutical and biotechnology companies, growth in the proteomics market. On the other hand, emerging countries such as India and China providing lucrative opportunities for players operating in this segment are a few factors driving the industry's growth over the forecasting period.

Glycomics Market Key Developments:
In June 2019, Agilent Technologies (US) has launched InfinityLab LC/MSD iQ System.
In June 2018, Thermo Fisher Scientific (US) had launched UHMR Hybrid Quadrupole-Orbitrap Mass Spectrometer.